Market Cap 1.66B
Revenue (ttm) 0.00
Net Income (ttm) -182.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 578,700
Avg Vol 739,066
Day's Range N/A - N/A
Shares Out 45.03M
Stochastic %K 75%
Beta 1.72
Analysts Strong Sell
Price Target $93.88

Latest News on APGE

Apogee Therapeutics: Engineering Biologic Dominance

Apr 14, 2025, 8:04 AM EDT - 13 days ago

Apogee Therapeutics: Engineering Biologic Dominance


Apogee Therapeutics Announces Agenda for Virtual R&D Day

Nov 29, 2024, 1:00 PM EST - 5 months ago

Apogee Therapeutics Announces Agenda for Virtual R&D Day


Apogee Therapeutics: Infrequent Dosing Advantage In Biotech Play

Jun 18, 2024, 10:05 AM EDT - 11 months ago

Apogee Therapeutics: Infrequent Dosing Advantage In Biotech Play


Apogee Therapeutics Begins $100 Million IPO Rollout

Jun 26, 2023, 1:30 PM EDT - 1 year ago

Apogee Therapeutics Begins $100 Million IPO Rollout